Wallace S L, Singer J Z, Duncan G J, Wigley F M, Kuncl R W
Department of Medicine, State University of New York Health Sciences Center, Brooklyn.
J Rheumatol. 1991 Feb;18(2):264-9.
In order to establish the degree of renal malfunction necessary for colchicine toxicity in patients receiving it daily for the prevention of recurrent acute gout, we obtained serum creatinine levels and measured or estimated creatinine clearances in a consecutive series of 17 patients with demonstrated colchicine myotoxicity. An estimate of creatinine clearance, based on ideal body weight and age, was nearly always 50 ml/min or less, and was the most practical predictor of the risk of toxicity. By comparison, patients with gout from the same clinical data base, but without myotoxicity, had normal renal function. The data yield clear guidelines for safe use of colchicine chronically.
为确定每日服用秋水仙碱预防复发性急性痛风的患者发生秋水仙碱毒性所需的肾功能损害程度,我们获取了17例已证实有秋水仙碱肌毒性患者的血清肌酐水平,并测量或估算了肌酐清除率。基于理想体重和年龄估算的肌酐清除率几乎总是50毫升/分钟或更低,是毒性风险最实用的预测指标。相比之下,来自同一临床数据库但无肌毒性的痛风患者肾功能正常。这些数据为长期安全使用秋水仙碱提供了明确的指导原则。